Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012–2017 | Zendy

Wenjia Zhu | Zendy; Michael E. Chernew | Zendy; Tisamarie B. Sherry | Zendy; Nicole Maestas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012–2017

Author(s) -

Wenjia Zhu,

Michael E. Chernew,

Tisamarie B. Sherry,

Nicole Maestas

Publication year - 2019

Publication title -

new england journal of medicine

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmsa1807069

Subject(s) - medicine , medical prescription , opioid , opioid epidemic , drug overdose , opioid related disorders , emergency medicine , pediatrics , poison control , pharmacology , receptor

The United States is undergoing a crippling opioid epidemic, spurred in part by overuse of prescription opioids by adults 25 to 64 years of age. Of concern are long-duration and high-dose initial prescriptions, which place the patients and their friends and relatives at heightened risk for long-term opioid use, misuse, overdose, and death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research